ImmuCell
ICCC
27 hedge funds and large institutions have $9.18M invested in ImmuCell in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 2 closing their positions.
30% more capital invested
Capital invested by funds: $7.04M → $9.18M (+$2.14M)
0.92% more ownership
Funds ownership: 11.37% → 12.29% (+0.92%)
7% less funds holding
Funds holding: 29 → 27 (-2)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRC
Shufro Rose & Co
New York
|
+$553K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$320K |
| 3 |
Morgan Stanley
New York
|
+$88.9K |
| 4 |
BL
Bleichroeder LP
New York
|
+$76.1K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$8.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Overbrook Management Corp
New York
|
-$255K |
| 2 |
Renaissance Technologies
New York
|
-$113K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$30.3K |
| 4 |
EFS
Essex Financial Services
Essex,
Connecticut
|
-$14.8K |
| 5 |
Koshinski Asset Management
Decatur,
Illinois
|
-$8.63K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
TCWM
27
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$5K | -648 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$1K | -100 | Closed |
|
ICCC Hedge Fund Activity: Q1 2022 in Review
27 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2022, worth a combined $9.18M — up 30% from $7.04M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ICCC and 0 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Shufro Rose & Co, adding an estimated $553K. The largest seller was Overbrook Management Corp, cutting an estimated $255K.
- 27 institutional investors held ImmuCell (ICCC) as of Q1 2022, down from 29 in Q4 2021.
- Funds reported $9.18M of ImmuCell stock for Q1 2022, up 30% quarter-over-quarter.
- 0 funds opened new ImmuCell positions in Q1 2022 and 2 closed out, a net change of -2 holders.
- The largest ImmuCell buyer in Q1 2022 was Shufro Rose & Co, an estimated $553K added.
- The largest ImmuCell seller in Q1 2022 was Overbrook Management Corp, an estimated $255K sold.
Based on aggregated 13F filings for Q1 2022.